Characterization and regulation of ADAMTS-16

Area of Science:

• Biochemistry
• Molecular Biology
• Genetics

Background:

• The ADAMTS (a disintegrin and metalloproteinase domain with thrombospondin motifs) family comprises 19 secreted proteinases.
• ADAMTS16 is a recently identified member with unknown function, notably expressed in cartilage and synovium, with elevated levels in osteoarthritis patients.

Purpose of the Study:

• To investigate the function of ADAMTS16 in chondrocytes.
• To characterize the transcriptional regulation of the human ADAMTS16 gene.

Main Methods:

• Cloning of ADAMTS16 cDNA and stable overexpression in chondrosarcoma cells.
• Analysis of cell proliferation, migration, adhesion, and MMP13 expression.
• Experimental identification of the transcription start point and promoter mapping.
• Investigation of transcription factor (Egr1, Sp1) and growth factor (TGFbeta) effects on ADAMTS16 promoter activity and gene expression.

Main Results:

• Overexpression of ADAMTS16 decreased chondrosarcoma cell proliferation and migration, but not adhesion.
• ADAMTS16 overexpression led to reduced expression of matrix metalloproteinase-13 (MMP13).
• The transcription start site and basal promoter of ADAMTS16 were identified, with Egr1 and Sp1 influencing promoter activity. TGFbeta stimulated endogenous ADAMTS16 expression.

Conclusions:

• ADAMTS16 plays a role in regulating chondrocyte proliferation, migration, and MMP13 expression.
• The findings provide insights into the transcriptional regulation of ADAMTS16, involving specific transcription factors and TGFbeta signaling.
• ADAMTS16 may be a potential target for therapeutic interventions in osteoarthritis.